UBC Medical Indonesia Tbk. vs Sidomulyo Selaras Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Sidomulyo Selaras Tbk. trades at Rp82 (market cap 182.31B, 6.2M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.2× Sidomulyo Selaras Tbk.'s market cap, and Sidomulyo Selaras Tbk. is more actively traded (6.2M versus 3.48M). Which is the better fit depends on your goals.
| LABS | SDMU | |
|---|---|---|
Market Cap | 576.7B | 182.31B |
Volume | 3.48M | 6.2M |
Lot | 34.82K | 62.05K |
Turnover | 522.79M | 504.06M |
Average Price | 150.13 | 81.24 |
Value | 522.79M | 504.06M |
Indicative Equilibrium Price | 148 | 82 |
Indicative Equilibrium Volume | 350 | 2.2K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →Sidomulyo Selaras Tbk (the company) was established on 13 Dec 1993 based on Notaries Deed No. 42 and the deed of establishment was approved by the the Ministry of Justice dated Feb 10, 1994. The Company’s articles of association has been amended several times, most recently by notarial deed No. 12 of F.Y Wijaya, S.H., dated Feb 28, 2011.
Read more on SDMU →